ifenprodil has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cardoso, JM; Carvalho, AL; Ferreira, IL; Ferreiro, E; Oliveira, CR; Pereira, CM; Rego, AC; Schmidt, J | 1 |
1 other study(ies) available for ifenprodil and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
Article | Year |
---|---|
Aβ and NMDAR activation cause mitochondrial dysfunction involving ER calcium release.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Beclomethasone; Calcium; Cerebral Cortex; Cognition; Cytosol; Endoplasmic Reticulum; Inositol 1,4,5-Trisphosphate Receptors; Membrane Potential, Mitochondrial; Mice, Transgenic; Mitochondria; Neurons; Piperidines; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Rotenone | 2015 |